Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Silberberg

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|May 1, 1978
Carcinogenesis hypothesisS Silberberg
Journal of Clinical Epidemiology|January 1, 1990
Estimating the benefits of cholesterol lowering: are risk factors for coronary heart disease multiplicative?J S Silberberg
Australian and New Zealand Journal of Medicine|December 1, 1994
After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart diseaseJ S Silberberg
Biorheology|June 1, 1973
The Aharon Katchalsky memorial lecture. "Life, flow and deformation"A S Silberberg
Journal of Learning Disabilities|October 1, 1979
A video program for special adolescentsB Ferguson, S Silberberg
The Canadian Journal of Cardiology|April 1, 1989
Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategiesJ S Silberberg, M McGregor
Clinical and Experimental Pharmacology & Physiology|January 1, 1988
Effect of 3 day infusion of ACTH or CRF on the pituitary-adrenal axisS Silberberg, J W Funder
The Medical Journal of Australia|November 18, 1991
The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trialsJ S Silberberg, D A Henry
The Medical Journal of Australia|November 18, 1991
The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 2. Implications for heart disease prevention in AustraliaJ S Silberberg, D A Henry
Anesthesia and Analgesia|October 1, 1989
Respiratory responses associated with release of intraoperative tourniquetsD L Bourke, M S Silberberg, R Ortega, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|May 1, 1978
Carcinogenesis hypothesisS Silberberg
Journal of Clinical Epidemiology|January 1, 1990
Estimating the benefits of cholesterol lowering: are risk factors for coronary heart disease multiplicative?J S Silberberg
Australian and New Zealand Journal of Medicine|December 1, 1994
After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart diseaseJ S Silberberg
Biorheology|June 1, 1973
The Aharon Katchalsky memorial lecture. "Life, flow and deformation"A S Silberberg
Journal of Learning Disabilities|October 1, 1979
A video program for special adolescentsB Ferguson, S Silberberg
The Canadian Journal of Cardiology|April 1, 1989
Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategiesJ S Silberberg, M McGregor
Clinical and Experimental Pharmacology & Physiology|January 1, 1988
Effect of 3 day infusion of ACTH or CRF on the pituitary-adrenal axisS Silberberg, J W Funder
The Medical Journal of Australia|November 18, 1991
The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trialsJ S Silberberg, D A Henry
The Medical Journal of Australia|November 18, 1991
The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 2. Implications for heart disease prevention in AustraliaJ S Silberberg, D A Henry
Anesthesia and Analgesia|October 1, 1989
Respiratory responses associated with release of intraoperative tourniquetsD L Bourke, M S Silberberg, R Ortega, et al.
Pageof 3